動画検索
関連広告
検索結果
Deborah Palestrant, Ph.D., Senior Director, Business Development and Strategy Cambridge, MA (NASDAQ: EDIT) Editas Medicine is a leading ...
YouTube-Alliance for Regenerative Medicine
2016/10/24動画の見どころ1/10枚目 Business Development
動画の見どころ2/10枚目 Business Development Strategy
動画の見どころ3/10枚目 DNA repair
動画の見どころ4/10枚目 Cut-and-remove panel
動画の見どころ5/10枚目 Editas delivery
動画の見どころ6/10枚目 Editas' Pipeline
動画の見どころ7/10枚目 Juneau collaboration
動画の見どころ8/10枚目 Editing in HSCs
動画の見どころ9/10枚目 Editas Partnerships
動画の見どころ10/10枚目 Editas' goals
Editas Medicine stock $EDIT has not sunk below its IPO price of $16 a share. That's after Editas stock peaked at $90 a share back in the ...
YouTube-Nanalyze
2022/06/11Dive into the Q4 2023 earnings presentation accompanied by the full earnings conference call, providing you with a complete understanding of ...
YouTube-Fyfull
1か月前Editas Medicine holds the patents of CRISPER. What are these patents worth today and in the future? ✌ Link to our Discord: ...
YouTube-Best of Us Investors
2023/01/31editas.medicine ... Link is in bio and our stories! . . . . . #sicklecell101 #curative101 #editasmedicine #vertexpharmaceuticals #bluebirdbio # ...
An editas medicine has highest number of patients filed. 18:13. Go to channel · Sandeep reviews BEAM Therapeutics (BEAM). Revenue recognition ...
YouTube-ShareTreck
1か月前The first CRISPR gene-editing medicine just got approved in the US! Here's what's happening: The new therapy called Casgevy treats sickle ...
YouTube-Cleo Abram
2023/12/10... Editas Medicine, PlugPower y Zscaler, compañías que están dejando su ... EditasMedicine #PlugPower #Zscaler #SDCAnalistas #VisiónGlobal ...
YouTube-Intereconomía
2024/01/11求める情報が見つからない場合は、キーワードや指定した条件を変えてみてください。